A phase II study of combination therapy with irinotecan and S-1 (IRIS) in patients with advanced colorectal cancer

M. Shiozawa,M. Akaike,N. Sugano,Kazuhito Tsuchida,N. Yamamoto,S. Morinaga
DOI: https://doi.org/10.1007/s00280-010-1278-0
2010-07-10
Cancer Chemotherapy and Pharmacology
Abstract:
What problem does this paper attempt to address?